litlas
Log inCreate account

Bas W.G. van Rhijn

Active 2001–2026

Also published as
Bas W. G. van Rhijn
98
Papers
20,220
Citations
54
h-index
91
i10-index

Citations

Citations per year for Bas W.G. van Rhijn1991: 1 citations2001: 4 citations2002: 5 citations2003: 16 citations2004: 17 citations2005: 47 citations2006: 49 citations2007: 42 citations2008: 25 citations2009: 34 citations2010: 66 citations2011: 50 citations2012: 57 citations2013: 65 citations2014: 70 citations2015: 91 citations2016: 94 citations2017: 100 citations2018: 116 citations2019: 621 citations2020: 734 citations2021: 720 citations2022: 526 citations2023: 450 citations2024: 774 citations2025: 321 citations2026: 19 citations1992–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,147 citing papers, 16.4% of this breakdownChina: 822 citing papers, 11.7% of this breakdownItaly: 502 citing papers, 7.2% of this breakdownGermany: 430 citing papers, 6.1% of this breakdownUnited Kingdom: 368 citing papers, 5.2% of this breakdownNetherlands: 351 citing papers, 5% of this breakdownFrance: 334 citing papers, 4.8% of this breakdownSpain: 290 citing papers, 4.1% of this breakdownCanada: 284 citing papers, 4% of this breakdownJapan: 270 citing papers, 3.9% of this breakdownAustria: 268 citing papers, 3.8% of this breakdownSwitzerland: 166 citing papers, 2.4% of this breakdown
0%16.4%Other 25.4%

Institutions

Fields

  • Medicine79.8%
  • Biochemistry, Genetics and Molecular Biology15.4%
  • Immunology and Microbiology2%
  • Engineering0.9%
  • Computer Science0.8%
  • Chemistry0.3%
  • Other0.8%

Topics

  • Bladder and Urothelial Cancer Treatments25.6%
  • Urinary and Genital Oncology Studies13.6%
  • Ferroptosis and cancer prognosis4%
  • Epigenetics and DNA Methylation3.3%
  • Cancer Immunotherapy and Biomarkers2.5%
  • Urological Disorders and Treatments2.2%
  • Other48.8%

Coauthors

All papers

Open in search
  1. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

    Authors: Marko Babjuk, Maximilian Burger, Otakar Čapoun, Daniel L. Cohen, Éva Compérat, J.L. Domínguez Escrig, Paolo Gontero, Fredrik Liedberg, A. Masson-Lecomte, Hugh Mostafid, Joan Palou, Bas W.G. van Rhijn, Morgan Rouprêt, Shahrokh F. Shariat, Thomas Seisen, Viktor Soukup, Richard Sylvester - European Urology 2021 cited by 1,623

  2. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update

    Authors: Morgan Rouprêt, Thomas Seisen, Alison Birtle, Otakar Čapoun, Éva Compérat, José L. Domínguez-Escrig, Irene Gürses Andersson, Fredrik Liedberg, Paramananthan Mariappan, Hugh Mostafid, Benjamin Pradère, Bas W.G. van Rhijn, Shahrokh F. Shariat, Bhavan Prasad, Francesco Soria, Viktor Soukup, Robbert G. Wood, Évanguelos Xylinas, A. Masson-Lecomte, Paolo Gontero - European Urology 2023 cited by 503

  3. European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

    Authors: Richard Sylvester, Óscar Rodríguez, Virginia Hernández, Diana Turturica, Lenka Bauerová, Harman Max Bruins, Johannes Bründl, Theodorus van der Kwast, A. Brisuda, J. Rubio‐Briones, Maximilian Seles, Anouk E. Hentschel, V.R.M. Kusuma, Nicolai Huebner, Juliette Cotte, Laura S. Mertens, Dimitrios Volanis, Olivier Cussenot, José Daniel Subiela, Enrique de la Peña, Francesca Pisano, Michael Pešl, Antoine G. van der Heijden, Sonja Herdegen, Alexandre R. Zlotta, Jaromír Háček, Ana Calatrava, Sebastian Mannweiler, Judith Bosschieter, David Ashabere, Andrea Haitel, Jean‐François Côté, Soha El Sheikh, Luca Lunelli, Ferrán Algaba, Isabel Alemany, Francesco Soria, Willemien Runneboom, Johannes Breyer, Jakko A. Nieuwenhuijzen, Carlos Llorente, Luca Molinaro, Christina A. Hulsbergen‐van de Kaa, Matthias Evert, Lambertus A. Kiemeney, James N’Dow, Karin Plass, Otakar Čapoun, Viktor Soukup, José L. Domínguez-Escrig, Daniel L. Cohen, Joan Palou, Paolo Gontero, Maximilian Burger, Richard Zigeuner, Amir Hugh Mostafid, Shahrokh F. Shariat, Morgan Rouprêt, Éva Compérat, Marko Babjuk, Bas W.G. van Rhijn - European Urology 2021 cited by 463

  4. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

    Authors: Marko Babjuk, Maximilian Burger, Éva Compérat, Paolo Gontero, Hugh Mostafid, Joan Palou, Bas W.G. van Rhijn, Morgan Rouprêt, Shahrokh F. Shariat, Richard Sylvester, Richard Zigeuner, Otakar Čapoun, Daniel L. Cohen, J.L. Domínguez Escrig, Virginia Hernández, B. Peyronnet, Thomas Seisen, Viktor Soukup - European Urology 2019 cited by 1,327

  5. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update

    Authors: Morgan Rouprêt, Marko Babjuk, Maximilian Burger, Otakar Čapoun, Daniel L. Cohen, Éva Compérat, Nigel C. Cowan, José L. Domínguez-Escrig, Paolo Gontero, Hugh Mostafid, Joan Palou, B. Peyronnet, Thomas Seisen, Viktor Soukup, Richard Sylvester, Bas W.G. van Rhijn, Richard Zigeuner, Shahrokh F. Shariat - European Urology 2020 cited by 941

  6. Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

    Authors: Roland Seiler, H.A.D.M. Ashab, Nicholas Erho, Bas W.G. van Rhijn, Brian Winters, James J. Douglas, Kim E. van Kessel, Elisabeth E. Fransen van de Putte, Matthew Sommerlad, Natalie Q. Wang, Voleak Choeurng, Ewan A. Gibb, Beatrix Palmer-Aronsten, Lucia L.C. Lam, Christine Buerki, Elai Davicioni, Gottfrid Sjödahl, Jordan Kardos, Katherine A. Hoadley, Seth P. Lerner, David J. McConkey, Woonyoung Choi, William Y. Kim, Bernhard Kiss, George N. Thalmann, Tilman Todenhöfer, Simon J. Crabb, Scott North, Ellen C. Zwarthoff, Joost L. Boormans, Jonathan L. Wright, Marc Dall’Era, Michiel S. van der Heijden, Peter C. Black - European Urology 2017 cited by 792

  7. EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

    Authors: Marko Babjuk, Andreas Böhle, Maximilian Burger, Otakar Čapoun, Daniel L. Cohen, Éva Compérat, Virginia Hernández, Eero Kaasinen, Joan Palou, Morgan Rouprêt, Bas W.G. van Rhijn, Shahrokh F. Shariat, Viktor Soukup, Richard Sylvester, Richard Zigeuner - European Urology 2016 cited by 2,298

  8. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

    Authors: Morgan Rouprêt, Marko Babjuk, Éva Compérat, Richard Zigeuner, Richard Sylvester, Maximilian Burger, Nigel C. Cowan, Andreas Böhle, Bas W.G. van Rhijn, Eero Kaasinen, Joan Palou, Shahrokh F. Shariat - European Urology 2015 cited by 1,344

  9. High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial

    Authors: Jeroen van Dorp, Christodoulos Pipinikas, Britt B.M. Suelmann, Niven Mehra, Nick van Dijk, Giovanni Marsico, Maurits L. van Montfoort, Sophie Hackinger, Linde M. Braaf, Tauanne Amarante, Charlaine van Steenis, Kirsten McLay, Antonios Daletzakis, Daan van den Broek, Maaike W. van de Kamp, Kees Hendricksen, Jeantine M. de Feijter, Thierry N. Boellaard, Richard P. Meijer, Antoine G. van der Heijden, Nitzan Rosenfeld, Bas W.G. van Rhijn, Greg Jones, Michiel S. van der Heijden - Nature Medicine 2023 cited by 78

  10. Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

    Authors: Bas W.G. van Rhijn, Maximilian Burger, Yair Lotan, Eduardo Solsona, Christian G. Stief, Richard Sylvester, J. Alfred Witjes, Alexandre R. Zlotta - European Urology 2009 cited by 760

  11. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update

    Authors: Paolo Gontero, Alison Birtle, Otakar Čapoun, Éva Compérat, José L. Domínguez-Escrig, Fredrik Liedberg, Paramananthan Mariappan, A. Masson-Lecomte, Hugh Mostafid, Benjamin Pradere, Bhavan Prasad, Bas W.G. van Rhijn, Thomas Seisen, Shahrokh F. Shariat, Francesco Soria, Viktor Soukup, Robert E. Wood, Évanguelos Xylinas - European Urology 2024 cited by 239

  12. Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review

    Authors: Viktor Soukup, Otakar Čapoun, Daniel L. Cohen, Virginia Hernández, Marek Babjuk, Max M. Burger, Éva Compérat, Paolo Gontero, Thomas Lam, Steven MacLennan, Hugh Mostafid, Joan Palou, Bas W.G. van Rhijn, Morgan Rouprêt, Shahrokh F. Shariat, Richard Sylvester, Yuhong Yuan, Richard Zigeuner - European Urology 2017 cited by 286

  13. Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial

    Authors: Hielke M. de Vries, Tynisha S. Rafael, Alberto Gil-Jimenez, Jeantine M. de Feijter, Elise M. Bekers, Elsbeth van der Laan, Marta López‐Yurda, Erik Hooijberg, Annegien Broeks, Dennis Peters, Iris M. Seignette, Floris J. Pos, Simon Horenblas, Bas W.G. van Rhijn, Ekaterina S. Jordanova, Oscar R. Brouwer, Eva Schaake, Michiel S. van der Heijden - Journal of Clinical Oncology 2023 cited by 69

  14. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non–muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non–muscle-invasive Bladder Cancer Guidelines Panel Study

    Authors: Bas W.G. van Rhijn, Anouk E. Hentschel, Johannes Bründl, Éva Compérat, Virginia Hernández, Otakar Čapoun, H.M. Bruins, Daniel L. Cohen, Morgan Rouprêt, Shahrokh F. Shariat, Hugh Mostafid, Richard Zigeuner, José L. Domínguez-Escrig, Maximilian Burger, Viktor Soukup, Paolo Gontero, Joan Palou, Theodorus van der Kwast, Marko Babjuk, Richard Sylvester, Bas W.G. van Rhijn, Anouk E. Hentschel, Johannes Bründl, Éva Compérat, Karin Plass, Óscar Rodríguez, José Daniel Subiela, Virginia Hernández, Enrique de la Peña, Isabel Alemany, Diana Turturica, Francesca Pisano, Francesco Soria, Otakar Čapoun, Lenka Bauerová, Michael Pešl, H.M. Bruins, Willemien Runneboom, Sonja Herdegen, Johannes Breyer, A. Brisuda, Ana Calatrava, J. Rubio‐Briones, Maximilian Seles, Sebastian Mannweiler, Judith Bosschieter, V.R.M. Kusuma, David Ashabere, Nicolai Huebner, Juliette Cotte, Laura S. Mertens, Daniel L. Cohen, Luca Lunelli, Olivier Cussenot, Soha El Sheikh, Dimitrios Volanis, Jean‐François Côté, Morgan Rouprêt, Andrea Haitel, Shahrokh F. Shariat, Hugh Mostafid, Jakko A. Nieuwenhuijzen, Richard Zigeuner, José L. Domínguez-Escrig, Jaromír Háček, Alexandre R. Zlotta, Maximilian Burger, Matthias Evert, Christina A. Hulsbergen ‐ van de Kaa, Antoine G. van der Heijden, Lambertus A. Kiemeney, Viktor Soukup, Luca Molinaro, Paolo Gontero, Carlos Llorente, Ferrán Algaba, Joan Palou, James N’Dow, Theodorus van der Kwast, Marko Babjuk, Richard J. Sylvester - European Urology Oncology 2021 cited by 101

  15. EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

    Authors: Marko Babjuk, Maximilian Burger, Richard Zigeuner, Shahrokh F. Shariat, Bas W.G. van Rhijn, Éva Compérat, Richard Sylvester, Eero Kaasinen, Andreas Böhle, Joan Palou Redorta, Morgan Rouprêt - European Urology 2013 cited by 1,175

  16. The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer

    Authors: Nick van Dijk, Alberto Gil-Jimenez, Karīna Siliņa, Maurits L. van Montfoort, Sarah Einerhand, Lars Jonkman, Charlotte S. Voskuilen, Dennis Peters, Joyce Sanders, Yoni Lubeck, Annegien Broeks, Erik Hooijberg, Daniël J. Vis, Maries van den Broek, Lodewyk F.A. Wessels, Bas W.G. van Rhijn, Michiel S. van der Heijden - Frontiers in Immunology 2021 cited by 40

  17. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel

    Authors: Thomas Seisen, B. Peyronnet, José L. Domínguez-Escrig, Harman Max Bruins, Cathy Yuhong Yuan, Marko Babjuk, Andreas Böhle, Maximilian Burger, Éva Compérat, Nigel C. Cowan, Eero Kaasinen, Joan Palou, Bas W.G. van Rhijn, Richard Sylvester, Richard Zigeuner, Shahrokh F. Shariat, Morgan Rouprêt - European Urology 2016 cited by 318

  18. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy

    Authors: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, Magali Michaut, Andreas Schlicker, Dennis Peters, Arno Velds, Marja Nieuwland, Michel M. van den Heuvel, Ron Kerkhoven, Lodewijk F.A. Wessels, Annegien Broeks, Bas W.G. van Rhijn, René Bernards, Michiel S. van der Heijden - European Urology 2015 cited by 218

  19. Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

    Authors: Roland Seiler, Ewan A. Gibb, Natalie Q. Wang, Htoo Zarni Oo, Hung‐Ming Lam, Kim E. van Kessel, Charlotte S. Voskuilen, Brian Winters, Nicholas Erho, Mandeep Takhar, James J. Douglas, Funda Vakar‐Lopez, Simon J. Crabb, Bas W.G. van Rhijn, Elisabeth E. Fransen van de Putte, Ellen C. Zwarthoff, George N. Thalmann, Elai Davicioni, Joost L. Boormans, Marc Dall’Era, Michiel S. van der Heijden, Jonathan L. Wright, Peter C. Black - Clinical Cancer Research 2018 cited by 126

  20. FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†

    Authors: Bas W.G. van Rhijn, Laura S. Mertens, Roman Mayr, Peter J. Boström, Francisco X. Real, Ellen C. Zwarthoff, Joost L. Boormans, Cheno Abas, Geert J.L.H. van Leenders, S. A. Gotz, Katrin Hippe, Simone Bertz, Y. Neuzillet, Joyce Sanders, Annegien Broeks, Michiel S. van der Heijden, Michael A.S. Jewett, Mirari Márquez, Robert Stoehr, Alexandre R. Zlotta, Markus Eckstein, Yanish Soorojebally, Hossain Roshani, Maximilian Burger, Wolfgang Otto, François Radvanyi, Nanor Sirab, Damien Pouessel, Bernd Wullich, Theodorus van der Kwast, Núria Malats, Arndt Hartmann, Yves Allory, Tahlita C.M. Zuiverloon - European Urology 2020 cited by 89

  21. FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy

    Authors: Lucie C. Kompier, Irene Lurkin, Madelon N.M. van der Aa, Bas W.G. van Rhijn, Theodorus van der Kwast, Ellen C. Zwarthoff - PLoS ONE 2010 cited by 314

  22. Molecular Characterization of Neuroendocrine-like Bladder Cancer

    Authors: José Batista da Costa, Ewan A. Gibb, Trinity J. Bivalacqua, Yang Liu, Htoo Zarni Oo, David T. Miyamoto, Mohammed Alshalalfa, Elai Davicioni, Jonathan L. Wright, Marc Dall’Era, James J. Douglas, Joost L. Boormans, Michiel S. van der Heijden, Chin‐Lee Wu, Bas W.G. van Rhijn, Shilpa Gupta, Petros Grivas, Kent W. Mouw, Paari Murugan, Ladan Fazli, Seong Ra, Badrinath R. Konety, Roland Seiler, Siamak Daneshmand, Omar Y. Mian, Jason A. Efstathiou, Yair Lotan, Peter C. Black - Clinical Cancer Research 2019 cited by 101

  23. BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets

    Authors: Francesco Claps, Nicola Pavan, Luca Ongaro, Domenico Tierno, Gabriele Grassi, Carlo Trombetta, Gabriele Tulone, Alchiede Simonato, Riccardo Bartoletti, Laura S. Mertens, Bas W.G. van Rhijn, Maria Carmen Mir, Bruna Scaggiante - International Journal of Molecular Sciences 2023 cited by 60

  24. Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer

    Authors: Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras‐Sanz, Kristan van der Vos, Daniël J. Vis, Linde M. Braaf, Annegien Broeks, Ron Kerkhoven, Kim E.M. van Kessel, María J. Ribal, Antonio Alcaraz, Lodewyk F.A. Wessels, Roland Seiler, Jonathan L. Wright, Lourdes Mengual, Joost L. Boormans, Bas W.G. van Rhijn, Peter C. Black, Michiel S. van der Heijden - European Urology 2022 cited by 46